Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

September 22, 2023
You're invited to participate in Targeted Oncology's Community Case Forum the evening before the TxSCO 2023 Annual Conference on Friday, September 22nd at 3 pm at the Hyatt Regency Frisco- Dallas. Attend a case-based discussion on Myeloproliferative Neoplasms: Myelofibrosis and Polycythemia vera (MPN) or Extensive-Stage Small Cell Lung Cancer (SCLC) led by expert moderators following a networking …
September 22, 2023
In this workshop, provided by the France Foundation, interactive formats will allow the multidisciplinary care team to continuously assess knowledge gaps.
Updates in Metastatic Breast Cancer treatment Ajit K Bisen, MD, MBA Dept of General Oncology Dept of Breast Medical Oncology UT MD Anderson Cancer Center Disclosures Advisory Board/Consulting • Gilead 4/2023 • Biotheranostics 5/2023 Globally, 684996 deaths and over 2.3 million cases of breast cancer last year Stage IV Regional Localized …
Texas Society of Clinical Oncology Annual Conference 2023 Presented By: Laith Abushahin MBBS @LAbushahin Updates in Gastrointestinal Malignancies Laith Abushahin MBBS Texas Oncology Baylor Charles A Sammons Cancer Center Dallas, Texas Gastrointestinal Malignancies 2023 estimates: • ~ 340 k new Cases. ~ 166 k deaths in 2023 in USA.1 • ~ 12,260 cancer deaths out of …
Building Meaningful Diversity, Equity, and Inclusivity into Oncology Practice Dr. Richard Lewis Martin III, MD, MPH (he/him/his) Medical Director, Health Equity and Community Engagement Tennessee Oncology President: ACCC - Tennessee Oncology Practice Society (TOPS) Disclosures • Funding • U54 CA0914010 (NCI) • 09/01/2021-08/31/2025 • Meharry-Vanderbilt-TSU Cancer Partnership …
Genetic Companion Testing in Oncology The Importance of Genetic Counseling and Testing For Hereditary Cancer Syndromes Gayle Patel, MS, CGC Texas Oncology About Me I have no disclosures Importance of Diagnosis of Hereditary Cancer Syndromes Enhanced Surveillance Treatment Options Cascade Testing …
Managing CAR T Cell Toxicity: Strategies and Insights Sai Ravi Pingali MD Associate Professor of Clinical Medicine Houston Methodist Hospital 09/23/2023 Conflict of Interests Attended Ad Board of Cardinal Health From Bench to Bedside: The History and Progress of CAR T Cell Therapy. Mitra A. et. al. Frontiers in Immunology. May 2023. Approved CAR T TherapiesApproved …
Assessing the prevalence and current trends in the use of cannabidiol (CBD) products in patient with active malignancy Krishna Suthar, MD1 krishna.suthar@bswhealth.org Jess Hatfield, BS2 Patricia Meyer, PharmD2 Lucas Wong, MD1 1Division of Hematology & Medical Oncology, Department of Internal Medicine Baylor Scott and White - Temple 2Texas A&M School of Medicine, …
Systemic Immune Parameters after Prior Radiation Therapy in Patients Receiving Immune Checkpoint Inhibitors Vatsala Mundra, Yuqiu Ynag, Mitchell S. von Itzstein, Farjana Fattah, Amrit Gonuganta, Raquibul Hannan, Laurentiu Pop, Yuanyuan Zhang, Yiqing Wang, Thomas Sheffield, Yang Xie, Jonathon Dowell, Jade Homsi, Sawsan Rashdan, Jason Park, Quan-Zhen Li, Edward Wakeland, David Gerber …
TxSCO Sept. 23, 2023 Federal & State Policy Updates Federal Updates Medicare PFS Reimbursement Cuts EOM Underway Medicaid Enrollment Shifts Stark Law & In-Office Dispensing: Mail-Order Prescriptions No Surprises Act Prescription Drug Pricing: “Government Negotiation” Underway Key Federal Policy Issues 3 PFS Proposed Rule 2024: More …
Optimal Timing Between Total Neoadjuvant Therapy and Surgery for Patients with Rectal Adenocarcinoma Megan Mai, MPH1; Jodi Goldman1, Duke Appiah, PhD, MPH2; Zheng Shi, MD, PhD3 1School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 2Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, Texas 3Department of Internal Medicine, Texas …
Exploring Minimally Invasive Interventional Strategies in Hepatocellular Carcinoma Patients: A Comparative Study ADVISOR Dr. Michael Kueht, MD 09/23/2023 The University of Texas Medical Branch, Galveston, TX PRIMARY AUTHOR Anuttham Kandhadai, BS Research Background & MotivationI Including transarterial (chemo)embolization (TAE), surgical resection (SR), radiofrequency …
Navigating Workforce Challenges in Healthcare Moderator: Ray Page, DO, PhD, FACOI, FASCO; The Centers for Blood and Cancer Disorders Colleen Gallagher, PhD, MS, LSW, FACHE, HECC; UT MD Anderson Cancer Center Fay J. Hlubocky, PhD, MA, CCTP, FASC, FASCO; University of Chicago Medicine Todd Pickard, MMSc, PA-C, DFAAPA, FASCO; UT MD Anderson Cancer Center Team-based Staffing …
Texas Oncology Precision Medicine Program 9/20/20232 Summary of TxO PM Program P a ti e n t C a re R e s e a rc h , C li n . T ri a ls E d u c a ti o n • Scalable • Equitable • Easy to Use • Consider the Patient’s Journey – Expand treatment options – Enroll more patients in clinical trials – Selecting treatment …
PRECISION MEDICINE in COMMUNITY ONCOLOGY: A BLUEPRINT Chris Prakash, MD Director Quality Services Lori Brisbin VP Precision Medicine TEXAS ONCOLOGY CASE • 60-year-old male with a 3 cm left hilar mass and multiple liver lesions. c/o abd pain, abnormal LFTs. FNA of liver- adenocarcinoma. PET scan–no other disease. Patient presents to you. • Do you initiate therapy …
The Centers for Medicare and Medicaid Services has recently proposed reimbursement for Principal Illness Navigation services under Medicare to help patients navigate treatment for serious illnesses such as cancer.
2009 Cancer Care Trends in Community Cancer Centers To identify and compare trends in conditions and organizational performance in the oncology marketplace, the Association of Community Cancer Centers (ACCC) initiated an annual survey of its membership in July 2008. The survey provides ACCC with information to assist members in evaluating their organizations’ performance. The survey will …
Year three of the Association of Community Cancer Centers' member survey provides insight into how cancer programs are working to control costs, implement new standards, launch new organizational strategies, and better serve patients. Christian Downs, JD, MHA Executive Director, ACCC Cancer Care Trends in Community Cancer Centers – A Survey of ACCC Membership 2012 …
Most characterized their program’s financial status as good or very good for 2010, similar to Year 2. However, more than one-third (34%) of programs do not have sufficient data to track profit and loss (P&L). While many programs are actively seeking to reduce or control costs without compromising quality and services, several respondents said that their financial strategy is skewed more toward …
This publication is a benefit of membership Association of Community Cancer Centers Vol. 38 | No. 5 | 2023 Exploring community-engaged research in pancreatic cancer | 51 Developing a cancer center support group training program | 44 Trending in Cancer Care Part II | 19 ISSUES ONCOLOGY Developing a Disease-Site Specific Oncology Patient Navigation Program